Constitutive rac activation is not sufficient to initiate melanocyte neoplasia but accelerates malignant progression

Journal of Investigative Dermatology

Volumn 133, Issue 6, 2013, Pages 1572-1581

  Dalton, Lucy E ^a,d   Kamarashev, Jivko ^b   Barinaga Rementeria Ramirez, Irene ^c   White, Gavin ^a   Malliri, Angeliki ^a   Hurlstone, Adam ^c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; RAC PROTEIN; RAC1 PROTEIN; RAF PROTEIN; RAS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BENIGN TUMOR; CANCER GROWTH; CARCINOGENICITY; DERMIS; DYSPLASTIC NEVUS; EMBRYO; EPIDERMIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING; MELANOCYTE; MELANOMA; MELANOMA CELL; METASTASIS; NONHUMAN; ONCOGENE RAS; PATHOGENESIS; PIGMENTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; ZEBRA FISH;

EID: 84878583077     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2013.23     Document Type: Article

References (28)

1. Benitah SA, Frye M, Glogauer M et al. (2005) Stem cell depletion through epidermal deletion of Rac1. Science 309:933-5
2. Berger MF, Hodis E, Heffernan TP et al. (2012) Melanoma genome sequencing reveals frequent PREX2 mutations. Nature 485:502-6
3. Corbetta S, Gualdoni S, Albertinazzi C et al. (2005) Generation and characterization of Rac3 knockout mice. Mol Cell Biol 25:5763-76
4. Hodis E, Watson IR, Kryukov GV et al. (2012) A landscape of driver mutations in melanoma. Cell 150:251-63
5. Jordan P, Brazao R, Boavida MG et al. (1999) Cloning of a novel human Rac1b splice variant with increased expression in colorectal tumors. Oncogene 18:6835-9
6. Kamai T, Yamanishi T, Shirataki H et al. (2004) Overexpression of RhoA, Rac1, and Cdc42 GTPases is associated with progression in testicular cancer. Clin Cancer Res 10:4799-805
7. Khosravi-Far R, Solski PA, Clark GJ et al. (1995) Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation. Mol Cell Biol 15:6443-53
8. Kissil JL, Walmsley MJ, Hanlon L et al. (2007) Requirement for Rac1 in a K-ras induced lung cancer in the mouse. Cancer Res 67:8089-94
9. Krauthammer M, Kong Y, Ha BH et al. (2012) Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet 44:1006-14
10. Lazer G, Katzav S (2011) Guanine nucleotide exchange factors for RhoGTPases: good therapeutic targets for cancer therapy? Cell Signal 23:969-79
11. Li A, Ma Y, Jin M et al. (2012) Activated Mutant NRas(Q61K) drives aberrant melanocyte signaling, survival, and invasiveness via a Rac1-dependent mechanism. J Invest Dermatol 132:2610-21
12. Li A, Ma Y, Yu X et al. (2011) Rac1 drives melanoblast organization during mouse development by orchestrating pseudopod- driven motility and cellcycle progression. Dev Cell 21:722-34
13. Lindsay CR, Lawn S, Campbell AD et al. (2011) P-Rex1 is required for efficient melanoblast migration and melanoma metastasis. Nat Commun 2:555
14. Mack NA, Whalley HJ, Castillo-Lluva S et al. (2010) The diverse roles of Rac signaling in tumorigenesis. Cell Cycle 10:1571-81
15. Madhunapantula SV, Mosca PJ, Robertson GP (2011) The Akt signaling pathway: an emerging therapeutic target in malignant melanoma. Cancer Biol Ther 12:1032-49
16. Malliri A, ten Klooster JP, Olivio C et al. (2002a) Determination of the activity of Rho-like GTPases in cells. Methods Mol Biol 189:99-109
17. Malliri A, van der Kammen RA, Clark K et al. (2002b) Mice deficient in the Rac activator Tiam1 are resistant to Ras-induced skin tumours. Nature 417:867-71
18. Michailidou C, Jones M, Walker P et al. (2009) Dissecting the roles of Raf- and PI3K-signalling pathways in melanoma formation and progression in a zebrafish model. Dis Model Mech 2:399-411
19. Michiels F, Habets GG, Stam JC et al. (1995) A role for Rac in Tiam1-induced membrane ruffling and invasion. Nature 375:338-40
20. Pan Y, Bi F, Liu N et al. (2004) Expression of seven main Rho family members in gastric carcinoma. Biochem Biophys Res Commun 315:686-91
21. Patton EE, Widlund HR, Kutok JL et al. (2005) BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma. Curr Biol 15:249-54
22. Qiu RG, Chen J, Kirn D et al. (1995) An essential role for Rac in Ras transformation. Nature 374:457-9
23. Rygiel TP, Mertens AE, Strumane K et al. (2008) The Rac activator Tiam1 prevents keratinocyte apoptosis by controlling ROS-mediated ERK phosphorylation. J Cell Sci 121:1183-92
24. Samuel MS, Lourenco FC, Olson MF (2011) K-Ras mediated murine epidermal tumorigenesis is dependent upon and associated with elevated Rac1 activity. PLoS One 6:e17143
25. Schnelzer A, Prechtel D, Knaus U et al. (2000) Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b. Oncogene 19:3013-20
26. Wang Z, Pedersen E, Basse A et al. (2010) Rac1 is crucial for Ras-dependent skin tumor formation by controlling Pak1-Mek-Erk hyperactivation and hyperproliferation in vivo. Oncogene 29:3362-73
27. Warycha MA, Christos PJ, Mazumdar M et al. (2008) Changes in the presentation of nodular and superficial spreading melanomas over 35 years. Cancer 113:3341-8
28. Woodcock SA, Rushton HJ, Castaneda-Saucedo E et al. (2010) Tiam1-Rac signaling counteracts Eg5 during bipolar spindle assembly to facilitate chromosome congression. Curr Biol 20:669-75